My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 692

    1.

    Corticotropin Releasing Factor promotes breast cancer cell motility and invasiveness.

    Androulidaki A, Dermitzaki E, Venihaki M, Karagianni E, Rassouli O, Andreakou E, Stournaras C, Margioris AN, Tsatsanis C.

    Mol Cancer. 2009 Jun 2;8:30.PMID: 19490624 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.

    Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, Pannell L, Shevde LA, Samant RS.

    Breast Cancer Res. 2008;10(2):R22. Epub 2008 Mar 7.PMID: 18328103 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression.

    Larkins TL, Nowell M, Singh S, Sanford GL.

    BMC Cancer. 2006 Jul 10;6:181.PMID: 16831226 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines.

    Hijazi MM, Thompson EW, Tang C, Coopman P, Torri JA, Yang D, Mueller SC, Lupu R.

    Int J Oncol. 2000 Oct;17(4):629-41.PMID: 10995872 [PubMed - indexed for MEDLINE]Related articles

    5.

    Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase.

    Yu HG, Tong SL, Ding YM, Ding J, Fang XM, Zhang XF, Liu ZJ, Zhou YH, Liu QS, Luo HS, Yu JP.

    Int J Cancer. 2006 Dec 15;119(12):2724-32.PMID: 16998832 [PubMed - indexed for MEDLINE]Related articles

    6.

    Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.

    Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W, Yuan Z.

    BMC Cancer. 2009 Apr 1;9:102.PMID: 19338666 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells.

    Kallergi G, Agelaki S, Markomanolaki H, Georgoulias V, Stournaras C.

    Cell Physiol Biochem. 2007;20(6):977-86.PMID: 17982280 [PubMed - indexed for MEDLINE]Related articles

    8.

    JAM-A expression positively correlates with poor prognosis in breast cancer patients.

    McSherry EA, McGee SF, Jirstrom K, Doyle EM, Brennan DJ, Landberg G, Dervan PA, Hopkins AM, Gallagher WM.

    Int J Cancer. 2009 Sep 15;125(6):1343-51.PMID: 19533747 [PubMed - indexed for MEDLINE]Related articles

    9.
    10.

    Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway.

    Baril P, Gangeswaran R, Mahon PC, Caulee K, Kocher HM, Harada T, Zhu M, Kalthoff H, Crnogorac-Jurcevic T, Lemoine NR.

    Oncogene. 2007 Mar 29;26(14):2082-94. Epub 2006 Oct 9.PMID: 17043657 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Correlation of expression of RhoC with invasiveness of prostate cancer cell line PC-3M in vitro]

    Yuan Z, Su J, You JF, Wang JL, Cui XL, Zheng J.

    Zhonghua Yi Xue Za Zhi. 2008 Jan 1;88(1):51-5. Chinese. PMID: 18346381 [PubMed - indexed for MEDLINE]Related articles

    13.

    Distinct signaling pathways regulate differential opioid effects on actin cytoskeleton in malignant MCF7 and nonmalignant MCF12A human breast epithelial cells.

    Kallergi G, Tsapara A, Kampa M, Papakonstanti EA, Krasagakis K, Castanas E, Stournaras C.

    Exp Cell Res. 2003 Aug 1;288(1):94-109.PMID: 12878162 [PubMed - indexed for MEDLINE]Related articles

    14.

    The cancer chemopreventive agent resveratrol induces tensin, a cell-matrix adhesion protein with signaling and antitumor activities.

    Rodrigue CM, Porteu F, Navarro N, Bruyneel E, Bracke M, Romeo PH, Gespach C, Garel MC.

    Oncogene. 2005 May 5;24(20):3274-84.PMID: 15735708 [PubMed - indexed for MEDLINE]Related articles

    15.

    Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.

    Afify A, Purnell P, Nguyen L.

    Exp Mol Pathol. 2009 Apr;86(2):95-100. Epub 2009 Jan 6.PMID: 19167378 [PubMed - indexed for MEDLINE]Related articles

    16.

    Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype.

    Graziani G, Tentori L, Muzi A, Vergati M, Tringali G, Pozzoli G, Navarra P.

    Mol Cell Endocrinol. 2007 Jan 29;264(1-2):44-9. Epub 2006 Nov 9.PMID: 17097220 [PubMed - indexed for MEDLINE]Related articles

    17.

    The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.

    Franzen CA, Amargo E, Todorović V, Desai BV, Huda S, Mirzoeva S, Chiu K, Grzybowski BA, Chew TL, Green KJ, Pelling JC.

    Cancer Prev Res (Phila Pa). 2009 Sep;2(9):830-41. Epub 2009 Sep 8.PMID: 19737984 [PubMed - indexed for MEDLINE]Related articles

    18.

    TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells.

    Simeone AM, McMurtry V, Nieves-Alicea R, Saavedra JE, Keefer LK, Johnson MM, Tari AM.

    Breast Cancer Res. 2008;10(3):R44. Epub 2008 May 12.PMID: 18474097 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.

    Chang HL, Sugimoto Y, Liu S, Wang LS, Huang YW, Ye W, Lin YC.

    Anticancer Res. 2009 Aug;29(8):3195-205.PMID: 19661335 [PubMed - indexed for MEDLINE]Related articles

    20.

    Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis.

    Fraser SP, Diss JK, Chioni AM, Mycielska ME, Pan H, Yamaci RF, Pani F, Siwy Z, Krasowska M, Grzywna Z, Brackenbury WJ, Theodorou D, Koyutürk M, Kaya H, Battaloglu E, De Bella MT, Slade MJ, Tolhurst R, Palmieri C, Jiang J, Latchman DS, Coombes RC, Djamgoz MB.

    Clin Cancer Res. 2005 Aug 1;11(15):5381-9. Erratum in: Clin Cancer Res. 2005 Nov 15;11(22):8224. PMID: 16061851 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk